Last $107.32 USD
Change Today +0.37 / 0.35%
Volume 99.8K
TFX On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 08/19/14 All times are local (Market data is delayed by at least 15 minutes).

teleflex inc (TFX) Snapshot

Open
$106.95
Previous Close
$106.95
Day High
$107.57
Day Low
$106.84
52 Week High
07/30/14 - $111.24
52 Week Low
08/20/13 - $75.23
Market Cap
4.4B
Average Volume 10 Days
182.5K
EPS TTM
$4.29
Shares Outstanding
41.4M
EX-Date
08/13/14
P/E TM
25.0x
Dividend
$1.36
Dividend Yield
1.27%
Current Stock Chart for TELEFLEX INC (TFX)

Related News

No related news articles were found.

teleflex inc (TFX) Related Businessweek News

No Related Businessweek News Found

teleflex inc (TFX) Details

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company operates in three segments: Vascular, Anesthesia/Respiratory, and Surgical. It offers vascular access products that facilitate various critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and taking of blood samples through a single puncture site; anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand; respiratory care products, such as oxygen therapy, aerosol therapy, spirometry, and ventilation management products under the Hudson RCI brand; and specialty products, including interventional access products, and products provided to specialty market customers. The company also provides surgical products, such as ligation and closure products used in surgical procedures; access ports for use in minimally invasive surgical procedures; fluid management products for use in chest drainage; and reusable hand-held instruments for general and specialty surgical procedures under the Deknatel, Pilling, Pleur-evac, Taut, and Weck brands. In addition, it offers cardiac care products comprising diagnostic catheters, including thermodilution and wedge pressure catheters; angiographic and therapeutic delivery catheters; sheaths for femoral and trans-radial aortic access, and intra-aortic balloons; and capital equipment, such as intra-aortic balloon pumps under the Arrow brand. Further, the company provides original equipment manufacturing and development services. Teleflex Incorporated offers its products to hospitals and healthcare providers in approximately 150 countries through its direct sales force and distributors. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

11,400 Employees
Last Reported Date: 02/24/14
Founded in 1943

teleflex inc (TFX) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $826.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $441.5K
Executive Vice President and President of Ame...
Total Annual Compensation: $427.1K
Compensation as of Fiscal Year 2013.

teleflex inc (TFX) Key Developments

Teleflex Incorporated Announces Quarterly Dividend, Payable on September 15, 2014

Teleflex Incorporated announced that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 15, 2014 to shareholders of record at the close of business on August 15, 2014.

Teleflex Incorporated Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 29, 2014; Revises Earnings Guidance for the Full Year 2014

Teleflex Incorporated reported unaudited consolidated earnings results for the second quarter and six months ended June 29, 2014. For the quarter, the company reported net revenues of $468.105 million compared to $420.059 million a year ago. Income from continuing operations before interest and taxes was $74.752 million compared to $63.751 million a year ago. Income from continuing operations before taxes was $58.836 million compared to $49.483 million a year ago. Income from continuing operations was $48.830 million or $1.04 per diluted share compared to $43.401 million or $0.99 per diluted share a year ago. Net income attributable to common shareholders was $47.252 million or $1.02 per diluted share compared to $42.441 million or $0.98 per diluted share a year ago. Adjusted diluted earnings per share from continuing operations were $1.51, as compared to $1.27 in the prior year period, an increase of 18.9%. Better-than-expected revenue performance in the second quarter resulted from several factors, including the over performance of both Vidacare and Mayo acquisitions; ability to continue to generate higher revenue from price increases; an improvement in the sales of existing products resulting from a slight improvement in end-market utilization trends primarily in Europe; and as-reported revenue benefited from foreign exchange favorability. For the six months, the company reported net revenues of $906.651 million compared to $831.936 million a year ago. Income from continuing operations before interest and taxes was $133.772 million compared to $113.155 million a year ago. Income from continuing operations before taxes was $102.639 million compared to $84.851 million a year ago. Income from continuing operations was $84.099 million or $1.81 per diluted share compared to $71.102 million or $1.64 per diluted share a year ago. Net income attributable to common shareholders was $82.210 million or $1.78 per diluted share compared to $69.479 million or $1.61 per diluted share a year ago. Net cash provided by operating activities from continuing operations was $120.161 million compared to $56.243 million a year ago. Expenditures for property, plant and equipment were $30.850 million compared to $36.897 million a year ago. Payments for businesses and intangibles acquired, net of cash acquired was $28.535 million compared to $36.954 million a year ago. Net debt obligations at June 29, 2014 were $867.3 million compared to $902.7 million at December 31, 2013. Adjusted diluted earnings per share from continuing operations were $2.73 as compared to $2.33 in the prior year period. The improvement in cash flow generation was largely due to the growth in earnings, improved working capital, and reduced pension contributions. The company reaffirmed its full year 2014 constant currency revenue growth guidance range of 7% and 9%, and increased its full year 2014 adjusted diluted earnings per share guidance from a range of $5.35 to $5.55 to a range of $5.45 to $5.60. The company forecasted 2014 diluted earnings per share attributable to common shareholders in the range of $3.50 to $3.60 and intangible amortization expense, net of tax of $0.93. The company continue to project adjusted gross margin to be in a range between 52% and 52.5% for the year. The projected 2014 gross margin represents an increase of approximately 240 to 290 basis points over 2013. The company continue to expect adjusted operating margins, excluding intangible amortization expense, to increase by approximately 100 basis points to a range of 20% to 21%. The company remain on track to achieve a full year 2014 adjusted tax rate of 22.5% to 23.5%.

Teleflex Mulls Acquisitions

Teleflex Incorporated (NYSE:TFX) is looking for acquisitions. Benson Smith, Chief Executive Officer of Teleflex said, "I do think from, therefore, our acquisition strategy is really driven around the products that particularly strengthen our franchise rather than simply trying to get bigger for the sake of being bigger. And so, again, I think what you've seen in the past from us, which is acquisitions in the size of Vidacare and LMA, provided they meet our criteria, some investment, some continued investment in late-stage technology acquisitions, some continued investment in distributor acquisitions, is what you can expect, I think, over the next three years for sure".

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TFX:US $107.32 USD +0.37

TFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ansell Ltd A$19.76 AUD +0.02
Hill-Rom Holdings Inc $43.26 USD +0.18
PerkinElmer Inc $45.60 USD -0.26
Sirona Dental Systems Inc $80.56 USD +0.54
STERIS Corp $55.01 USD +0.36
View Industry Companies
 

Industry Analysis

TFX

Industry Average

Valuation TFX Industry Range
Price/Earnings 29.4x
Price/Sales 2.5x
Price/Book 2.2x
Price/Cash Flow 27.1x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TELEFLEX INC, please visit www.teleflex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.